30 Dec, 2022 09:58 AM
Sydney, Australia – 30 December 2022 – Radiopharm Theranostics (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, ...read more
08 Nov, 2022 11:30 AM
In accordance with ASX Listing Rule 3.10A, Radiopharm Theranostics (ASX:RAD) advises that the following shares will be released from escrow on 18 November 2022:
25,555,555 Ordinary Fully Paid Res...read more
08 Nov, 2022 11:29 AM
Radiopharm Theranostics Limited (ASX:RAD, “RAD” or the “Company”), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic u...read more
26 Oct, 2022 10:53 AM
Sydney, Australia and Beloit, Wisconsin, U.S. – October 26, 2022 -- Radiopharm Theranostics (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both ...read more